U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 3
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
1. Name and Address of Reporting Person: Mark A. Scharmann,
1661 Lakeview Circle, Ogden, UT 84403
2. Date of Event Requiring Statement (Month/Date/Year): 10/1/98
3. IRS or Social Security Number of Reporting Person (Voluntary):
4. Issuer Name and Ticker or Trading Symbol: ImmunoTechnology Corp (ITRXD)
5. Relationship of Reporting Person(s) to Issuer (Check all Applicable)
(X) Director (X) Officer, give title below ( ) 10% Owner ( ) Other
Title: Vice President
6. If Amendment, Date of Original (Month/Day/Year): N/A
7. Individual or Joint/Group Filing (Check Applicable Line)
(X) Form filed by One Reporting Person
( ) Form filed by More than One Reporting Person
TABLE I - Non-Derivative Securities Beneficially Owned
1. Title of Security: Common Stock
2. Amount of Securities Beneficially Owned: 86,850
3. Ownership Form: Direct(D)or Indirect(I): I
4. Nature of Indirect Beneficial Ownership: Shares beneficially held of
record by Troika Capital Investments, of which Mr. Scharmann is the principal
owner and shareholder
TABLE II - Derivative Securities Beneficially Owned
1. Title of Derivative Security: N/A
2. Date Exercisable (Month/Day/Year):
Expiration Date(Month/Day/Year):
3. Title:
Amount of Securities Underlying Derivative Security (Amount of Number of
shares):
4. Conversion or Exercise Price of Derivative Security:
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I):
6. Nature of Indirect Beneficial Ownership:
Explanation of Responses:
Signature of Reporting Person: /S/ Mark Scharmann
Date: 10/8/98
